<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000584343">
  <TermName>Levulan Kerastick</TermName>
  <TermPronunciation>(LEH-vyoo-lan KAYR-uh-stik)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that contains the active ingredient aminolevulinic acid hydrochloride and is used with photodynamic therapy to treat actinic keratosis (a skin condition that may become cancer).  When Levulan Kerastick is taken up by abnormal cells, including cancer cells, and then exposed to certain types of light, it becomes active and kills the cells. Levulan Kerastick is a type of photosensitizing agent.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000720697" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Levulan Kerastick&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000720696" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Levulan Kerastick&quot;" language="es" id="_4"/>
  <SpanishTermName>Levulan Kerastick</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene el principio activo  clorhidrato de ácido aminolevulínico y se utiliza en combinación con terapia fotodinámica para el tratamiento de la queratosis actínica (afección de la piel que a veces se convierte en cáncer). Las células anormales, como las células cancerosas, captan Levulan Kerastick y luego, cuando se exponen a ciertos tipos de luz, el medicamento se activa y las destruye. Levulan Kerastick es un tipo de fotosensibilizador.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-01-10</DateFirstPublished>
  <DateLastModified>2021-02-12</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000500167" url="/about-cancer/treatment/drugs/aminolevulinicacid">Aminolevulinic Acid Hydrochloride</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
